Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
insulin aspart (Novolog) (4 trials)
insulin human (humulin) (5 trials)
insulin lispro (humalog) (4 trials)
bosentan (tracleer) (1 trial)
memantine (namenda) (1 trial)
metformin (glucophage) (2 trials)
romiplostim (nplate) (1 trial)
darunavir (prezista) (1 trial)
fluconazole (diflucan) (1 trial)
insulin glargine (toujeo) (1 trial)
Molnupiravir (1 trial)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Trials (20 total)
Trial APIs (11 total)